Document:

EX-10.15

 Exhibit 10.15 
  

 
 October 18, 2011 

Michael D. Goldberg 
 Dear Michael, 

On behalf of XDx, Inc. (“XDx” or the “Company”) and the whole XDx team as well as XDx’ Board of Directors (the “Board”), I
am very pleased to offer you the position of Chairman of the Board. We believe that your deep and broad business background will enable you to make significant contributions to the Company’s efforts, and to help bring to a fruitful conclusion
the several strategic collaboration deals presently underway. We look forward to working with you toward what we believe is XDx’s imminent success. 

The terms of your position with XDx are set forth below: 
  

	 	1.	Position: Chairman of the Board. In addition to attending all regularly scheduled meetings of the Board of Directors, you agree to devote additional time to your role as is customary for a non-executive chairman
of the board. 

  

	 	2.	Start date. Your official start date shall be deemed to be October 14, 2011. Your appointment to the Board will occur upon receipt of the requisite stockholder approvals. 

 

	 	3.	Compensation. In your role, you will be paid at the rate of $100,000 per year, payable monthly, with any partial months of service pro-rated. In addition, upon signing this letter, an amount of $25,000 will be
immediately due and payable to you by the Company. Since your role is as an independent Board member and not an employee, no taxes will be withheld from your pay, and you will receive a 1099 earnings statement early in 2012 showing all earnings paid
through the end of 2011. If it is determined that you should be classified as an employee, you agree to indemnify the Company for any liability for taxes owed by you as an individual. You will also be entitled to a change of control bonus as
described below. 

  

	 	4.	Stock Options. In connection with your acceptance of the above stated position, the Board of Directors has agreed to grant you an option to purchase an amount equal to 1.0% of the fully diluted outstanding
capitalization of the Company as of September 9, 2011, which amounts to an option to purchase 442,000 shares of Common Stock of XDx (the “Initial Option”). The exercise price per share will equal the fair market value of the Common
Stock of XDx as of the date of grant, presently $0.43 per share. 

  
 1 

 

 
  

 Following the Company’s Next Equity Financing and subject to your continued service with
the Company, the Company will grant you an additional option for a number of shares that, when combined with the Initial Option and any other options granted to you, will equal 1.0% of the fully-diluted outstanding capitalization of the Company
immediately following such financing. As used herein, “Next Equity Financing” shall mean a financing or financings that total at least $25 million in gross proceeds, including conversion of debt, and includes at least $10 million in gross
proceeds from investors who are not stockholders of the Company at this time (the “Second Option” and together with the Initial Option, the “Options”). Any such Second Option shall have the same terms as the Initial Option,
including vesting commencement date, except that the exercise price will be the fair market value on the date of grant, as determined by the Board of Directors. 

The Options will vest based upon your continued service to the Company as its Chairman at the rate of 1/48th of the total number upon completion of each month of service. 6/48ths of the Options will immediately vest on the date that you sign and date this letter. The Options will vest in full in the event
of a Change of Control. You may elect to exercise the Options prior to vesting, providing that the Company will retain the right to repurchase unvested shares at cost upon termination of services. The Options will be nonqualified and therefore
subject to tax treatment different from the incentive option grants typically made to employees. You may have your questions in this regard answered either by Company counsel, Wilson Sonsini Goodrich & Rosati, or by Rebecca Soler,
XDx’s Vice President of Human Resources. 
  

	 	5.	Change of Control Bonus Plan. The Board intends to establish a standard Change of Control or “Carve-out” Bonus Plan for key executives and to include you as a participant in the Plan. The Plan will
establish a bonus pool based on a percentage of the net proceeds from a Change of Control transaction. “Net Proceeds” will be defined to mean the amount available for distribution to security holders (including investor notes and
distributions under the Plan), after deducting transaction expenses and certain third party debt. Each participant in the Plan will be allocated a percentage of the bonus pool, offset by the proceeds from any equity incentives granted to that
participant and adjusting for option exercise prices. The pool is expected to include 10% of Net Proceeds, plus an additional 5% of Net Proceeds above $100 million. With your participation, the Board will determine the participants and the
allocation among the participants. 

  
 2 

 

 
  

	 	6.	Term and Termination. The term of this position is intentionally unstated. Your services may be terminated at any time, with or without reason, by you, the Board of Directors or the stockholders. You agree to
resign from the Board at any time if requested by the majority of the Board of Directors or the holders of a majority in interest of the Company’s preferred stock. 

 

	 	7.	Proprietary or Confidential Information. In this position, you may receive from XDx information that is proprietary to the Company. Such information includes but is not limited to scientific, technical, or
business information of XDx. Therefore, by your acceptance of this position, you agree that you will not, either during or subsequent to the term of your relationship with the Company, directly or indirectly, disclose any proprietary information of
XDx, nor will you copy or use any proprietary information, except as necessary to carry out your work as Chairman. Further, you agree that you will not, either during or subsequent to the term of your relationship with the Company, publish any such
information without prior written authorization from XDx. You agree to notify the Company immediately in the event you become aware of any loss or disclosure of any proprietary information. To the fullest extent permitted under applicable law, from
the date of this Agreement until twelve (12) months after the termination of this Agreement for any reason you will not, without the Company’s prior written consent, directly or indirectly, solicit any of the Company’s employees to
leave their employment, or attempt to solicit employees of the Company, either for you or for any other person or entity. You and the Company will enter into a customary Confidentiality and Invention Assignment Agreement. 

 

	 	8.	Entire Agreement. This letter, along with the Director and Officer Indemnification Agreement, the Options and any agreements relating to proprietary rights between you and the Company, sets forth the entire
agreement between the parties relating to your services as Chairman. This letter may not be modified or amended except by a written agreement approved by the Board and signed by you and an officer of the Company. 

We are very pleased to be able to extend this offer, and look forward to working with you. To indicate your acceptance of this offer, please sign and date in
the spaces provided below. If you have any questions about anything contained in this offer, please feel free to contact me directly at 415-287-2321. 
  

	
	With best regards,
	
	/s/ Pierre Cassigneul
	
	Pierre Cassigneul
	President and Chief Executive Officer

  
 3 

 

 
  

			
	Agreed to and accepted:
		
	Signature:		 /s/ Michael D. Goldberg

			
		
	 Printed Name:
		 Michael D. Goldberg

			
		
	Date:		 October 31, 2011

 M. Goldberg XDx Chairman Offer Letter 

[Remainder of Page Intentionally Left Blank] 

  
 4EX-10.16

 Exhibit 10.16 
  

 
 OFFER LETTER 

December 3, 2014 
 John J. Sninsky, PhD 

1 Mira Flores 
 Orinda, CA 94563 

john.sninsky@gmail.com 
 Dear John: 

I am pleased to offer you a position with CareDx, Inc. (the “Company”) as Chief Scientific Officer reporting directly to me,
beginning January 5, 2015. This position is a full-time, exempt position, based at our headquarters in Brisbane, California. 

Effective upon commencement of your full-time employment at the Company you will receive an annualized salary of $314,415, paid on a
semi-monthly basis on our regular paydays. Deductions required by law or authorized by you will be taken from each paycheck. 
 We are
offering you a signing bonus of $15,000, which will be payable to you within 30 days after your first day of employment and the amount is subject to all state and federal taxes. A $10,000 consulting fee for 5 days of work in the month of December
2014 will also be paid out to you upon completion, please refer to the Consulting Agreement dated December 3, 2014 for further details. 

Additionally, you will be eligible to participate in our variable performance bonus plan, which has a current annual target of 40% of your
base salary. You must be employed at the time of payout and the amount is subject to all state and federal taxes. 
 As a Company employee,
you are also eligible to receive certain employee benefits pursuant to the terms of Company benefit plans as described in the Employee Handbook. You should note that the Company may modify, in its sole discretion, job titles, salaries, holidays,
vacation and any other benefits from time to time as it deems necessary. 
 Subject to the approval of the Board of Directors of the
Company, you will be granted an option to purchase 75,000 shares of the Company’s Common Stock. This option shall vest, subject to your continued employment with the Company, as to one fourth (1/4) of the shares on the one year anniversary
of your start date, and as to an additional one forty-eighth (1/48th) of the total number of shares subject to the option at the end of each calendar month thereafter. Details of the price of these options will be provided in your stock option
grant and determined by the board of directors. 

 John J. Sninsky, PhD 

December 3, 2014 
  

 You should be aware that your employment with the Company is for no specified period and
constitutes at will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause. 

For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility
for employment in the United States. Such documentation must be provided to us within three (3) business days of your date of hire, or our employment relationship with you may be terminated. Your employment also is subject to successful
verification of your professional references, and to our standard pre-employment process, which includes completion of an employment application and successful completion of a standard background check. 

As a condition to your employment with the Company, you will be required to sign the Company’s standard At-Will Employment, Confidential
Information, Invention Assignment, and Arbitration Agreement, a copy of which will be provided to you. 
 We also ask that, if you have not
already done so, you disclose to the Company any and all agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed. It is the Company’s
understanding that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case. Moreover, you agree that, during the term of your employment with the Company, you will not engage in
any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that
conflict with your obligations to the Company. Similarly, you agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any
way utilize any such information. 
 In the event of any dispute or claim relating to or arising out of our employment relationship, you and
the Company agree that all such disputes shall be fully and finally resolved by binding arbitration conducted by the American Arbitration Association in San Mateo County, California. 

REMAINDER OF PAGE 
 INTENTIONALLY
LEFT BLANK 

  
 2 

 John J. Sninsky, PhD 

December 3, 2014 
  

 This letter, along with the CareDx At-Will Employment, Confidential Information, Invention
Assignment, and Arbitration Agreement, sets forth the terms of your employment with the Company and supersede any prior representations or agreements, whether written or oral. This letter may be executed in any number of counterparts, each of which
shall be an original, but all of which together shall constitute one instrument. This letter may not be modified or amended except by a written agreement, signed by the Company and by you. To accept this offer, you may sign, date, and fax this
letter to Danny Wan, Human Resources Manager, at (415) 287-2544. Alternatively, you may scan a copy of the signed offer letter and e-mail it to Danny at Dwan@CareDxInc.com. This offer will expire on December 8, 2014. 

We look forward to working with you at CareDx, Inc. 

 

	
	Sincerely,
	
	CareDx, Inc.
	
	 /s/ Peter Maag

	Peter Maag
	President and CEO

  

	
	ACCEPTED AND AGREED TO this
	
	5 day of December, 2014.
	
	 /s/ John J. Sninsky

	John J. Sninsky, PhD

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00242-of-00352.parquet"}]]